Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
type 1 diabetes
4
×
biotech
clinical trials
eli lilly
fda
indiana blog main
life sciences
national blog main
new york blog main
beta bionics
boston blog main
boston top stories
deals
diabetes
indiana top stories
medical device
new york top stories
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
startups
adaptive biotechnologies
alector
allergan
american diabetes association
amgen
apollomics
arrowmark partners
artificial intelligence
bernie sanders
bigfoot biomedical
bill & melinda gates foundation trust
black diamond therapeutics
blood sugar
boehringer ingelheim
boston
boston university
boulder/denver blog main
boulder/denver top stories
What
diabetes
4
×
patients
eli
key
type
appetite
approval
beta
bid
bio
bionics
black
blood
boehringer
bread
butter
buyout
cancer
cash
catch
catching
closed
developing
device
diamond’s
driven
drug
drugs
earlier
early
expand
fallen
fda
giant
grabbed
hasn’t
heads
hold
ibm's
identify
Language
unset
Current search:
diabetes
×
" type 1 diabetes "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@engadget.com
4 years ago
AI could be the key to catching Type 1 diabetes much earlier
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests